Imaging3 becomes public company

Developer of real-time 3D diagnostic imaging tools Imaging3 Inc. has reported that it has gone public based on the acceptance of its SB-2 registration statement by the Securities and Exchange Commission (SEC).

"We are very pleased that our registration statement has been declared effective and that we have become a public company," said Dean Janes, CEO, Imaging3. "We can now turn our energies and focus to developing markets and customers for our breakthrough, real-time three dimensional medical imaging systems. We look forward to building a successful company for our shareholders," added Janes.

The company's 3D, real-time medical imaging technology is designed to enable healthcare workers to instantly view high resolution images of virtually any part of the human body in three dimensions and in real time. 3D images are instantly constructed using high-resolution fluoroscopy and can be used as real time references for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Imaging3 Technology may be used in a number of medical applications, including trauma center, cardiology, pain management, neuro-vascular, orthopedic and vascular procedures, the company said.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.